Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: A matched case-control study with 2 years of follow-up

M. Wijnen, D. S. Olsson, M. M. Van Den Heuvel-Eibrink, V. Wallenius, J. A.M.J.L. Janssen, P. J.D. Delhanty, A. J. Van Der Lely, G. Johannsson, S. J.C.M.M. Neggers

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

43 Citaten (Scopus)

Samenvatting

Background:Hypothalamic obesity is a devastating consequence of craniopharyngioma. Bariatric surgery could be a promising therapeutic option. However, its efficacy and safety in patients with craniopharyngioma-related hypothalamic obesity remain largely unknown.Objectives:We investigated the efficacy of bariatric surgery for inducing weight loss in patients with craniopharyngioma-related hypothalamic obesity. In addition, we studied the safety of bariatric surgery regarding its effects on hormone replacement therapy for pituitary insufficiency.Methods:In this retrospective matched case-control study, we compared weight loss after bariatric surgery (that is, Roux-en-Y gastric bypass and sleeve gastrectomy) between eight patients with craniopharyngioma-related hypothalamic obesity and 75 controls with 'common' obesity during 2 years of follow-up. We validated our results at 1 year of follow-up in a meta-analysis. In addition, we studied alterations in hormone replacement therapy after bariatric surgery in patients with craniopharyngioma.Results:Mean weight loss after bariatric surgery was 19% vs 25% (difference -6%, 95% confidence of interval (CI) -14.1 to 4.6; P=0.091) at 2 years of follow-up in patients with craniopharyngioma-related hypothalamic obesity compared with control subjects with 'common' obesity. Mean weight loss was 25% vs 29% (difference -4%, 95% CI -11.6 to 8.1; P=0.419) after Roux-en-Y gastric bypass and 10% vs 20% (difference -10%, 95% CI -14.1 to -6.2; P=0.003) after sleeve gastrectomy at 2 years of follow-up in patients with craniopharyngioma-related hypothalamic obesity vs control subjects with 'common' obesity. Our meta-analysis demonstrated significant weight loss 1 year after Roux-en-Y gastric bypass, but not after sleeve gastrectomy. Seven patients with craniopharyngioma suffered from pituitary insufficiency; three of them required minor adjustments in hormone replacement therapy after bariatric surgery.Conclusions:Weight loss after Roux-en-Y gastric bypass, but not sleeve gastrectomy, was comparable between patients with craniopharyngioma-related hypothalamic obesity and control subjects with 'common' obesity at 2 years of follow-up. Bariatric surgery seems safe regarding its effects on hormone replacement therapy.

Originele taal-2Engels
Pagina's (van-tot)210-216
Aantal pagina's7
TijdschriftInternational Journal of Obesity
Volume41
Nummer van het tijdschrift2
DOI's
StatusGepubliceerd - 1 feb. 2017

Vingerafdruk

Duik in de onderzoeksthema's van 'Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: A matched case-control study with 2 years of follow-up'. Samen vormen ze een unieke vingerafdruk.

Citeer dit